See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no definitive list of vaccines to avoid while on Cosentyx (secukinumab) [1]. However, the manufacturer recommends that live vaccines should be administered at least 4 weeks before starting Cosentyx, if possible [1]. This recommendation is due to the potential risk of infection associated with live vaccines [1].

It is important to note that the decision to administer vaccines while on Cosentyx should be made in consultation with a healthcare professional [1]. They will consider the individual's health status, the need for the vaccine, and the potential risks and benefits [1].

The Centers for Disease Control and Prevention (CDC) also advises that live vaccines should be given at least 4 weeks before starting immunosuppressive therapy like Cosentyx [2]. However, the CDC does not provide a specific list of vaccines to avoid [2].

In conclusion, while there is no specific list of vaccines to avoid while on Cosentyx, live vaccines should be administered at least 4 weeks before starting the medication if possible. The decision to administer vaccines while on Cosentyx should be made in consultation with a healthcare professional.

Sources:
[1] Novartis Pharmaceuticals Corporation. Cosentyx (secukinumab) [Prescribing Information]. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2021. Available from: https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf
[2] Centers for Disease Control and Prevention. Vaccination of Persons with Moderate or Severe Acute Illness. In: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Atlanta, GA: US Department of Health and Human Services; 2019. Available from: https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/index.html
[3] DrugPatentWatch. Secukinumab. In: Drugs.com. Washington, DC: DrugPatentWatch; 2021. Available from: https://www.drugs.com/ppa/secukinumab.html